Kathelijn S. Versteeg

Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer

S. Blauwhoff-Buskermolen, Kathelijn S. Versteeg, M.A.E. de van der Schueren et al. · Journal of Clinical Oncology · 2016 · 387 citations · Full text

Medicine, Oncology, Chemotherapy +16

Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial

Susan van der Lei, Robbert S. Puijk, Madelon Dijkstra et al. · The Lancet Oncology · 2025 · 145 citations · Full text

Medicine, Oncology, Surgery +16

Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group

Sanne Nieuwenhuizen, Robbert S. Puijk, Bente A. T. van den Bemd et al. · Cancers · 2020 · 109 citations · Full text

Medicine, Oncology, Surgery +17

Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer

Kathelijn S. Versteeg, S. Blauwhoff-Buskermolen, Laurien M. Buffart et al. · The Oncologist · 2017 · 83 citations · Full text

Medicine, Geriatric Medicine, Chemotherapy +9

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases

Koen P. Rovers, Checca Bakkers, Simon W. Nienhuijs et al. · JAMA Surgery · 2021 · 73 citations · Full text

Medicine, Perioperative Medicine, Surgery +17